Abstract
Introduction: Polyethylene wear debris is the main contributing factor that leads to aseptic loosening and osteolysis. The main objective of this study was to evaluate the role of hydroxyapatite (HA) in third-body polyethylene wear in total hip arthroplasty.
Materials: 199 primary cementless THA’s (174 patients) performed by a single surgeon were enrolled in a prospective randomized study comprising hydroxyapatite and non-hydroxyapatite coated femoral implants. The femoral component had metaphyseal-diaphyseal fit design with proximal plasma sprayed titanium circumferential porous coating. The hydroxyapatite coating was 50 – 75 micrometers over the porous surface with the components of identical design. The acetabular component was plasma sprayed titanium porous coated shell without hydroxyapatite. T he polyethylene liners were machined molded from ram extruded Hi-fax 1900H polyethylene resin gamma-sterilized in argon (inert) gas. Clinical and Radiographic evaluation was performed employing HSS scores and Engh criteria.
Results: At a mean follow-up of 5 years, the radiographs of 83 HA and 73 Non-HA hips were evaluated by two independent observers utilizing computer-assisted wear analysis on digitized standardized radiographs described by Martell et al (1997). The radiographs were also evaluated for osteolysis or aseptic loosening.
The mean linear wear rate in HA group was 0.19mm/yr and in the non-HA group was 0.21mm/yr, which was not significant (p> 0.05). There was no case of osteolysis or aseptic loosening of any component. Both groups had comparable outcomes in terms of HSS scores, walking ability and sports participation.
Discussion: This study has attempted to demonstrate through an appropriately controlled in vivo study that hydroxyapatite does not play a significant role in third-body polyethylene wear in THA at a mean follow-up of five years. The concern of three-body wear with hydroxyapatite coating is no greater than porous coated cementless implants.
The abstracts were prepared by Nico Verdonschot. Correspondence should be addressed to him at Orthopaedic Research Laboratory, University Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands.
